RT Journal Article
SR Electronic
T1 Characterization of Oral bacteriome dysbiosis in type 2 diabetic patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.09.20052613
DO 10.1101/2020.04.09.20052613
A1 Junaid Ahmed Kori
A1 Faizan Saleem
A1 Saeed Ullah
A1 M. Kamran Azim
YR 2020
UL http://medrxiv.org/content/early/2020/04/11/2020.04.09.20052613.abstract
AB We aimed to characterize the relationship of the oral microbiome with diabetes in Pakistan. Saliva samples were collected from diabetic patients (n = 49) and healthy individuals (n = 55). 16S metagenomics saliva was carried out by NGS technology. We observed that the phylum Firmicutes (p-value = 0.024 at 95% confidence interval) was significantly more abundant among diabetic patients than among the controls. We found that the abundance of phylum Actinobacteria did not significantly vary among both groups in contrast to a similar report from the USA (Long et al., 2017). On genus level, acidogenic bacteria Prevotella (p-value = 0.024) and Leptotrichia (p-value = 1.5 × 10−3); and aciduric bacteria Veillonella (p-value = 0.013) were found to be in higher abundance in diabetic patients. These bacteria are found in dental biofilm and involved in the metabolism of fermentable carbohydrates. Stratified analysis by gender revealed healthy and diabetic females to be more divergent. Abundance of Prevotella (p-value = 4.4 × 10-3) and Leptotrichia (p-value = 0.015) was significantly associated with male patients. A comparison of oral bacteriome between two groups revealed the dominance of acidogenic and aciduric bacteria in diabetics which suggested the involvement of these eubacteria in oral dysbacteriosis in diabetes mellitus.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study was approved by the Independent Ethics Committee (IEC), International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.Funding StatementThis research was supported by Higher Education Commission, PakistanAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data referred to in the manuscript will be available on request.